Brief: Shenzhen Neptunus Interlong Bio Technique issues positive profit alert
24/02/2017 13:01
Feb 24 (Reuters) - Shenzhen Neptunus Interlong Bio Technique
Co Ltd 8329.HK
* Group is expected to record a substantial increase in
profit attributable to owners of co for year ended 31 Dec 2016
* Expected results due to disposal of Taizhou Neptunus Nano
Bio-Medical Technology and Jiangsu Neptunus Bio-Pharmaceutical
Source text for Eikon: ID:nHKS5mXMkQ
Further company coverage: 8329.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Shenzhen Neptunus Interlong Bio-technique
See all newsBrief: Shenzhen Neptunus Interlong Bio-Technique's Unit Enters Into JV Agreement With Huikang Bio-Technology
China's Neptunus Interlong H1 revenue falls
Brief: Shenzhen Neptunus Interlong Bio-Technique Expects Net Profit Attributable To Owners Of RMB 7 Million For 2026 Interim Period
Brief: Shenzhen Neptunus Interlong Bio-Technique Posts FY Loss & Total Comprehensive Expenses Attributable RMB40.7 Million
Brief: Shenzhen Neptunus Interlong Bio-Technique Sees FY Net Loss Attributable Of RMB40 Million